Condition: Rheumatoid Arthritis
Intervention: Biological: Certolizumab pegol (CDP870)
Sponsor: UCB, Inc.
Active, not recruiting - verified February 2011
By ClinicalTrials.gov 
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.